The above results clearly indicate that Aurora-A contributes to cisplatin resistance by inhibiting cell senescence and promoting glycolysis through regulation of the SOX8/FOXK1 signaling pathway in ovarian cancer. Here, FOXK1 is linked to ovarian carcinoma.